Salvador Pons Vives

Hospital Son Llatzer

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Antonia Fuster Gomila

Hospital Son Llatzer

Javier Berraondo Fraile

Iberia (Spain)

Rubén Garrido Llamas

Iberia (Spain)

Andrés Maimó Bordoy

Hospital Son Llatzer

J M Barros Rodríguez

Aida Sánchez Dalmar

Hospital Son Llatzer

Adrián Rodríguez

Health Research Institute of the Balearic Islands

Pilar Gual Capllonch

Hospital Son Llatzer

Andrés López Pardo

Hospital Son Llatzer

Antonio Albaladejo Dávalos

Hospital Son Llatzer

Cooperative Institutions

Hospital Son Llatzer

Iberia (Spain)

Universidad Católica de Córdoba

Hospital Terrassa

Universidade Presbiteriana Mackenzie

Hospital General Universitario De Valencia

Health Research Institute of the Balearic Islands

Florida SouthWestern State College

Queen Mary University of London

Centro de Ingeniería Genética y Biotecnología

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Effectiveness of a Multidisciplinary COPD Respiratory Unit (MUCOPD). A retrospective study.

05.02 - Monitoring airway disease (2024)

Elisabet Serra Amer Adrián Rodríguez J M Barros Rodríguez Salvador Pons Vives Antonia Fuster Gomila

10.1183/13993003.congress-2024.pa1240

Cite

Citations (0)

Antonio Albaladejo Dávalos Pilar Gual Capllonch Javier Berraondo Fraile Andrés Maimó Bordoy Antonia Fuster Gomila

Introduction: The effectiveness of oxygen therapy in COPD patients is well known when the time of use is correct. Aim: The aim of our study is determinate the factors related with therapy adherence due to improve the leak time of oxygen therapy use we detect in our patients. Methods: We included all outpatients with COPD and with oxygen therapy from our hospital. We analyzed demographic, clinic and adherence data. Statistical analysis was made using Chi square, T-test and multivariate analysis. Statistical significance p<0.05. Results: We included 108 COPD patients with oxygen therapy (58.3% men; age:72.9±1.2). The median of treatment is 23.5 months (IQR:10.4–58.9). Most of them are chronic bronchitis (61%) and GOLD D (44.8%). At least one comorbidity in 89.8% (Charlson Index:5.7±0.2) and 73% have another respiratory comorbidity (41.5% OSA; 16.9% bronchiectasis; 41.6% other). The 79.6% use the therapy less than 16 h/day. There are differences statistically significant between the use registered by the concentrator and the self-referred use (9.8±0.6 vs 12±0.8 h/day; p<0.05). A statistically significant correlation is been detected between the self-referred use and qualification (r=-0.3; p<0.05). Some factors related with adherence were analyzed. Breathlessness degree (by mMRC) and the presence of comorbidity, like solid tumor, are statistically significant (p<0.05 and p<0.01 respectively). However, there are not association with other factors (p>0.05). Conclusions: Most of the patients use the oxygen therapy less than the minimum of 16 hours/day. Only the degree of breathlessness and the presence of comorbidity could determinate the adherence. The self-referred use of the therapy is higher than the real.

Oxygen therapy

Chronic bronchitis

10.1183/1393003.congress-2017.pa3898

Cite

Citations (0)

Follow up of OSA patients after 10 years of diagnosis

Javier Berraondo Fraile Andrés López Pardo Aida Sánchez Dalmar Andrés Maimó Bordoy Zaid Al-Nakeeb

Aim: The aim is to analyze the evolution of the OSA patients diagnosed 10 years ago. Methods: We included all patients diagnosed in 2005. We analyzed demographic, clinic, sleepiness and comorbidities at the moment of the diagnosis and at 5 and 10 years of follow up. We compare two groups: those that go on with the CPAP treatment after 10 years (group A) and those that gave it up (group B). Results: We included 173 OSA patients: 134 in group A and 39 in group B. Most of them were men (81.6%) of 63.8±1.9 mean age at diagnosis. Most had AHI>30 (72.2%) diagnosed by PSG (87.2%). There were patients with sleepiness (Epworth 12.2±0.5), active life (workers 81.3%), non-smokers (40.8%) and obese (IMC:37.6±2.7Kg/m2). At diagnosis at least 33.6% had one comorbidity. No statistical differences between groups. The reasons to give up the treatment were: death (12.8%), non-adherence (38.5%), patient decision (30.8%) and others (17.9%). Patients in group A maintained the therapy adherence throw the years (5.24h/night, 5.57h/night at 5 and 10 years respectively; p=0.43). During the follow up, patients presented new comorbidities (35.79% group A vs 65.52% group B; p<0.01). There were a statistical significative increase of the proportion of hypertension, diabetes and dyslipidemia in both groups, but not significative between groups. In these 10 years 52.63% of patients in group A were recovered and 59.26% in group B (p=0.3); 38% by cardiovascular or respiratory reasons in A vs 47.37% in B (p=0.48). Conclusions: The main reasons to give up the treatment are: patients decision and adherence. Those that give up the treatment present an increase of the comorbidities. The presence of cardiovascular risk factor increase parallel in both groups.

Dyslipidemia

Group B

Group A

10.1183/1393003.congress-2017.pa2272

Cite

Citations (0)